Actually Wegovy is good for dialysis companies, dialysis provider says

At least according to the CEO of Fresenius Medical Care, a dialysis provider whose shares have been volatile since Novo Nordisk’s GLP-1 medicine demonstrated long-term benefits for patients with obesity last year.